This finding is consistent with the literature indicating that chronic IFN signaling within the tumor microenvironment can drive T cell dysfunction and exhaustion, ultimately limiting tumor control (17), i.e., it is suggestive of an immune cytotoxic response that has failed and is no longer functional. The gene discussed is IFNA1; the disease is neoplasm.